Approved comparison material connected to this topic.
9 total recordsSource comparisons are presented without a generated winner.
Loading Phase 0.25–0.5mg Daily 5–7 days Start day 4, 4–6 hours post-injection, 10–15 min Receptor saturation, initial melanogenesis, baseline tan established Maintenance Phase 0.5–1mg Twice weekly (e.g., Mon/T…
Loading (Sunless) 0.25–0.5mg Daily 10–14 days Visible tan by day 7–10; stabilises week 3–4 Mild to moderate nausea, flushing Maintenance (Sunless) 0.5–1mg Twice weekly Ongoing Stable tan maintained indefinitel…
Initial Loading (Days 1–7) 250mcg Daily (evening) None on Days 1–2; 5–8 min UV-A on Days 3, 5, 7 Visible baseline tan by Day 5–7 Slow titration prevents nausea and establishes even MC1R activation across all m…
0.5–1.5mg per dose, 2–3x/week Libido enhancement, central arousal, spontaneous erection 60–90 minutes 6–8 hours Mild flushing, stretching/yawning at higher end of range Therapeutic window for sexual function r…
Melanotan-2 MC4R agonism in hypothalamus. Central appetite circuit modulation 30–60 minutes 4–8 hours Daily, pre-meal Rapid-onset, short-duration intervention. Ideal for targeting specific eating windows rathe…
On-Demand 2–4 hours before activity 0.5–2mg per dose 2–4 hours 6–12 hours Planned sexual activity, infrequent use, minimizing systemic exposure Maintenance (Low-Dose) 2–3 times per week 0.25–0.5mg per dose Cum…
It’s worth briefly mentioning Melanotan 2’s sibling, Melanotan 1. While they sound similar, they have key differences that are important for researchers. Melanotan 1 is much more selective for the MC1R, the re…
Researchers often ask us about the differences between Melanotan 1 and its successor. While they share a name and primary function, their nuanced receptor affinities lead to different research applications. Un…
It's easy to get MT-1 and MT-2 confused, but they are distinct compounds with different research profiles. While both are analogues of α-MSH, their structure and receptor binding affinity differ, leading to di…